HIV-1 Vpr potently induces programmed cell death in the CNS in vivo

DNA and Cell Biology

Volumn 26, Issue 2, 2007, Pages 116-131

  Cheng, Xiandong ^a   Mukhtar, Muhammad ^b   Acheampong, Edward A ^a   Srinivasan, Algarsamy ^a   Rafi, Mohammad ^a   Pomerantz, Roger J ^c   Parveen, Zahida ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c Tibotec Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS VECTOR; VPR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; BRAIN REGION; CELL COUNT; CELL CYCLE ARREST; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CHOROID PLEXUS; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; MOUSE; NEUROPATHOLOGY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS ENVELOPE; VIRUS EXPRESSION; VIRUS PARTICLE;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN; CELLS, CULTURED; GENE PRODUCTS, VPR; GENETIC VECTORS; HIV-1; HUMANS; MICE; MICE, INBRED C57BL; OLIGODENDROGLIA; TRAGER DUCK SPLEEN NECROSIS VIRUS; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MUS; SPLEEN NECROSIS VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 33847683896     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2006.0541     Document Type: Article

References (51)

1. ACHEAMPONG, E.A., PARVEEN, Z., MUTHOGA, L.W., KALAYEH, M., MUKHTAR, M., et al. (2005). Human immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases. J. Virol. 79, 4257-4269.
2. AHMAD, N. (2005). The vertical transmission of human immunodeficiency virus type 1: Molecular and biological properties of the virus. Crit. Rev. Clin. Lab. Sci. 42, 1-34.
3. ANDERSON, E., ZINK, W., XIONG, H., and GENDELMAN, H.E. (2002). HIV-1-associated dementia: A metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J. Acquir. Immune Defic. Syndr. 31(Suppl. 2):S43-S54.
4. BENOS, D.J., McPHERSON, S., HAHN, B.H., CHAIKIN, M.A., and BENVENISTE, E.N. (1994a). Cytokines and HIV envelope glycoprotein gp120 stimulate Na+/H+ exchange in astrocytes. J. Biol. Chem. 269, 13811-13816.
5. BENOS, D.J., HAHN, B.H., SHAW, G.M., BUBIEN, J.K., and BENVENISTE, E.N. (1994b). gp120-mediated alterations in astrocyte ion transport. Adv. Neuroimmunol. 4, 175-179.
6. BURDO, T.H., NONNEMACHER, M., IRISH, B.P., CHOI, C.H., KREBS, F.C., et al. (2004). High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia. DNA Cell Biol. 23, 261-269.
7. BURNS, J.C., FRIEDMANN, T., DRIEVER, W., BURRASCANO, M., and YEE, J.K. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90, 8033-8037.
8. CHANG, L.J., CHEN, C.H., URLACHER, V., and LEE, T.Z. (2000). Differential apoptosis effects of primate lentiviral Vpr and Vpx in mammalian cells. J. Biomed. Sci. 7, 322-333.
9. FRADE, J.M., RODRIGUEZ-TEBAR, A., and BARDE, Y.A. (1996). Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383, 166-168.
10. GARDEN, G.A. (2002). Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 40, 240-251.
11. GARDEN, G.A., BUDD, S.L., TSAI, E., HANSON, L., KAUL, M., et al. (2002). Caspase cascades in human immunodeficiency virus-associated neurodegeneration. J. Neurosci. 22, 4015-4024.
12. GAUTIER, R., JIANG, A., ROUSSEAU, V., DORNBURG, R., and JAFFREDO, T. (2000). Avian reticuloendotheliosis virus strain A and spleen necrosis virus do not infect human cells. J. Virol. 74, 518-522.
13. GOH, W.C., MANEL, N., and EMERMAN, M. (2004). The human immunodeficiency virus Vpr protein binds Cdc25C: Implications for G2 arrest. Virology 318, 337-349.
14. HE, J., DECASTRO, C.M., VANDENBARK, G.R., BUSCIGLIO, J., and GABUZDA, D. (1997). Astrocyte apoptosis induced by HIV-1 transactivation of the c-kit protooncogene. Proc. Natl. Acad. Sci. USA 94, 3954-3959.
15. HEINZINGER, N.K., BUKINSKY, M.I., HAGGERTY, S.A., RAGLAND, A.M., KEWALRAMANI, V., et al. (1994). The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91, 7311-7315.
16. HUANG, M.B., WEEKS, O., ZHAO, L.J., SALTARELLI, M., and BOND, V.C. (2000). Effects of extracellular human immunodeficiency virus type 1 vpr protein in primary rat cortical cell cultures. J. Neurovirol. 6, 202-220.
17. JANA, A., and PAHAN, K. (2004). Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase. J. Neurosci. 24, 9531-9540.
18. JANOO, A., MORROW, P.W., and TUNG, H.Y. (2005). Activation of protein phosphatase-2A(1) by HIV-1 Vpr cell death causing peptide in intact CD(4+) T cells and in vitro. J. Cell Biochem. 94, 816-825.
19. JIAN, H., and ZHAO, L.J. (2003). Pro-apoptotic activity of HIV-1 auxiliary regulatory protein Vpr is subtype-dependent and potently enhanced by nonconservative changes of the leucine residue at position 64. J. Biol. Chem. 278, 44326-44330.
20. LANGFORD, D., ADAME, A., GRIGORIAN, A., GRANT, I., MCCUTCHAN, J.A., et al. (2003). Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J. Acquir. Immune Defic. Syndr. 34, 467-474.
21. LANGFORD, D., MARQUIE-BECK, J., DE ALMEIDA, S., LAZZARETTO, D., LETENDRE, S., et al. (2006). Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. J. Neurovirol. 12, 100-107.
22. LAWRENCE, D.M., DURHAM, L.C., SCHWARTZ, L., SETH, P., MARIC, D., et al. (2004). Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells. J. Virol. 78, 7319-7328.
23. LUM, J.J., COHEN, O.J., NIE, Z., WEAVER, J.G., GOMEZ, T.S., et al. (2003). Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J. Clin. Invest. I11, 1547-1554.
24. MATSUDA, M., MATSUDA, N., WATANABE, A., FUJISAWA, R., YAMAMOTO, K., et al. (2003). Cell cycle arrest induction by an adenoviral vector expressing HIV-1 Vpr in bovine and feline cells. Biochem. Biophys. Res. Commun. 311, 748-753.
25. MOON, H.S., and YANG, J.S. (2006). Role of HIV Vpr as a regulator of apoptosis and an effector on bystander cells. Mol. Cells 21, 7-20.
26. MORIMOTO, K., HOOPER, D.C., SPITSIN, S., KOPROWSKI, H., and DIETZSCHOLD, B. (1999). Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J. Virol. 73, 510-518.
27. MORIMOTO, K., McGETTIGAN, J.P., FOLEY, H.D., HOOPER, D.C., DIETZSCHOLD, B., et al. (2001). Genetic engineering of live rabies vaccines. Vaccine 19, 3543-3551.
28. MUKHTAR, M., and POMERANTZ, R.J. (2000). Development of an in vitro blood-brain barrier model to study molecular neuropathogenesis and neurovirologic disorders induced by human immunodeficiency virus type 1 infection. J. Hum. Virol. 3, 324-334.
29. MUKHTAR, M., DUKE, H., BOUHAMDAN, M., and POMERANTZ, R.J. (2000). Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: An initial approach against a potential viral reservoir. Hum. Gene Ther. 11, 347-359.
30. NALDINI, L., BLOMER, U., GAGE, F.H., TRONO, D., and VERMA, I.M. (1996a). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93, 11382-11388.
31. NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., et al. (1996b). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
32. NATH, A. (2002). Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J. Infect. Dis. 186(Suppl 2), S193-S198.
33. PARVEEN, Z., KRUPETSKY, A., ENGELSTADTER, M., CICHUTEK, K., POMERANTZ, R.J., et al. (2000). Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells. Nat Biotechnol 18, 623-629.
34. PARVEEN, Z., MUKHTAR, M., RAFI, M., WENGER, D.A., SIDDIQUI, K.M., et al. (2003). Cell-type-specific gene delivery into neuronal cells in vitro and in vivo. Virology 314, 74-83.
35. PARVEEN, Z., MUKHTAR, M., GOODRICH, A., ACHEAMPONG, E., DORNBURG, R., et al. (2004). Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: Construction of a new generation of spleen necrosis virus-derived retroviral vectors. J Virol 78, 6480-6488.
36. PATEL, C.A., MUKHTAR, M., and POMERANTZ, R.J. (2000). Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J. Virol. 74, 9717-9726.
37. PATEL, C.A., MUKHTAR, M., HARLEY, S., KULKOSKY, J., and POMERANTZ, R.J. (2002). Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons. J. Neurovirol. 8, 86-99.
38. PILLER, S.C. (2001). Effect of extracellular HIV-1 Vpr protein in vitro. J. Neurovirol. 7, 183-185.
39. PILLER, S.C., JANS, P., GAGE, P.W., and JANS, D.A. (1998). Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: Implications for AIDS pathology. Proc. Natl. Acad. Sci. USA 95, 4595-4600.
40. POON, B., JOWETT, J.B., STEWART, S.A., ARMSTRONG, R.W., RISHTON, G.M., et al. (1997). Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard. J. Virol. 71, 3961-3971.
41. SHERMAN, M.P., SCHUBERT, U., WILLIAMS, S.A., DE NORONHA, C.M., KREISBERG, J.F., et al. (2002). HIV-1 Vpr displays natural protein-transducing properties: Implications for viral pathogenesis. Virology 302, 95-105.
42. SINGH, I.N., GOODY, R.J., DEAN, C., AHMAD, N.M., LUTZ, S.E., et al. (2004). Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G. J. Neurovirol. 10, 141-151.
43. STEWART, S.A., POON, B., JOWETT, J.B., and CHEN, I.S. (1997). Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71, 5579-5592.
44. STRAIN, M.C., LETENDRE, S., PILLAI, S.K., RUSSELL, T., IGNACIO, C.C., et al. (2005). Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J. Virol. 79, 1772-1788.
45. TSAI, W.P., COPELAND, T.D., and OROSZLAN, S. (1985). Purification and chemical and immunological characterization of avian reticuloendotheliosis virus gag-gene-encoded structural proteins. Virology 140, 289-312.
46. VANITHARANI, R., MAHALINGAM, S., RAFAELI, Y., SINGH, S.P., SRINIVASAN, A., et al. (2001). HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro. Virology 289, 334-342.
47. WHEELER, E.D., ACHIM, C.L., and AYYAVOO, V. (2006). Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients. J. Neurovirol. 12, 200-210.
48. XU, Y., KULKOSKY, J., ACHEAMPONG, E., NUNNARI, G., SULLIVAN, J., et al. (2004). HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy. Proc. Natl. Acad. Sci. USA 101, 7070-7075.
49. YASUDA, J., MIYAO, T., KAMATA, M., AIDA, Y., and IWAKURA, Y. (2001). T cell apoptosis causes peripheral T cell depletion in mice transgenic for the HIV-1 vpr gene. Virology 285, 181-192.
50. ZHOU, B.Y., LIU, Y., KIM, B., XIAO, Y., and HE, J.J. (2004). Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes. Mol. Cell. Neurosci. 27, 296-305.
51. ZHU, H., JIAN, H., and ZHAO, L.J. (2004). Identification of the 15FRFG domain in HIV-1 Gag p6 essential for Vpr packaging into the virion. Retrovirology 1, 26.